ErbB Receptors, antagonists & inhibitors
- Name
- ErbB Receptors, antagonists & inhibitors
- Accession Number
- DBCAT005008
- Description
Not Available
- Drugs
Drug Drug Description Pelitinib Investigated for use/treatment in colorectal cancer and lung cancer. Necitumumab A monoclonal antibody used to treat metastatic squamous non-small cell lung cancer. BMS-599626 BMS-599626 has been used in trials studying the treatment of Cancer, Metastases, and HER2 or EGFR Expressing Advanced Solid Malignancies. Allitinib Allitinib is under investigation in clinical trial NCT04671303 (To Evaluate the Efficacy and Safety of Anlotinib Combined With Allitinib in Lung Cancer). - Drugs & Drug Targets